Description
Development and commercialization of pharmaceutical drug products derived from active pharmaceutical ingredients (APIs) synthesized and patented by its parent company.
See the website
Case studies
Investment: New uses for well-known molecules Provepharm, a private French pharmaceutical company focusing on new areas of discovery, wished to announce its €120M investment to enable it to make major steps forward in its Horizon 2025 strategy.
Read more